APA (7th ed.) Citation

Murphy, T., & Le Foll, B. (2020). Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs. Biomolecules (Basel, Switzerland), 10(6), 855. https://doi.org/10.3390/biom10060855

Chicago Style (17th ed.) Citation

Murphy, Thomas, and Bernard Le Foll. "Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs." Biomolecules (Basel, Switzerland) 10, no. 6 (2020): 855. https://doi.org/10.3390/biom10060855.

MLA (9th ed.) Citation

Murphy, Thomas, and Bernard Le Foll. "Targeting the Endocannabinoid CB1 Receptor to Treat Body Weight Disorders: A Preclinical and Clinical Review of the Therapeutic Potential of Past and Present CB1 Drugs." Biomolecules (Basel, Switzerland), vol. 10, no. 6, 2020, p. 855, https://doi.org/10.3390/biom10060855.